Cargando…
Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder
BACKGROUND: Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time following medication induction in which medication dose is adjusted to be effective...
Autores principales: | Langdon, Kirsten J., Ramsey, Susan, Scherzer, Caroline, Carey, Kate, Ranney, Megan L., Rich, Josiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191734/ https://www.ncbi.nlm.nih.gov/pubmed/32349790 http://dx.doi.org/10.1186/s13722-020-00189-4 |
Ejemplares similares
-
Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol
por: Langdon, Kirsten J., et al.
Publicado: (2023) -
Enhancing distress tolerance to uplift motivation in recovery:
Results from an open development trial
por: Bhuptani, Prachi H., et al.
Publicado: (2023) -
Feasibility and Acceptability of a Digital Health Intervention to Promote Continued Engagement in Medication for Opioid Use Disorder Following Release From Jail/Prison
por: Langdon, Kirsten J, et al.
Publicado: (2022) -
Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol
por: Claborn, Kasey, et al.
Publicado: (2018) -
Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol
por: Claborn, Kasey, et al.
Publicado: (2017)